Dianthus Therapeutics Announces Two Poster Presentations For DNTH103 At The 10th Congress Of The European Academy Of Neurology June 29-July 2, 2024
Dianthus Therapeutics Announces Two Poster Presentations For DNTH103 At The 10th Congress Of The European Academy Of Neurology June 29-July 2, 2024
Dianthus Therapeutics宣佈將在2024年6月29日至7月2日舉行的第10屆歐洲神經學院大會上舉辦兩個關於DNTH103的海報展示。
Dianthus Therapeutics, Inc. (NASDAQ:DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today announced two poster presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN), taking place June 29-July 2, 2024 in Helsinki.
致力於推進用於治療嚴重自身免疫性疾病的下一代抗體補體療法的臨床階段生物技術公司Dianthus Therapeutics, Inc.（納斯達克股票代碼：DNTH）今天在2024年6月29日至7月2日在赫爾辛基舉行的歐洲神經病學學會（EAN）第十屆大會上宣佈了兩張 DNTH103 海報演示。